CFO Vaibhav Taneja was the only named executive to receive an equity grant for 2024, the EV maker said in its annual report.
Pharmaceutical company Organon (NYSE:OGN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 6.7% year on year to $1.51
Economic consulting firm CRA International (NASDAQ:CRAI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.9% year
Security and healthcare technology company OSI Systems (NASDAQ:OSIS) announced better-than-expected revenue in Q1 CY2025, with sales up 9.6% year on year
Resource management provider Itron (NASDAQ:ITRI) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $607.2
UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls
CVS Health shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results easily topped estimates.
Higher education company Laureate Education (NASDAQ:LAUR) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 14.2% year
Biotech company Biogen (NASDAQ:BIIB) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 6.1% year on year to $2.43
Shares of Meta and Microsoft soared in premarket trading after the companies reported earnings. Will Apple and Amazon do the same?
